Resolve Therapeutics

Resolve Therapeutics Resolve Therapeutics is pioneering first-in-class compounds for primary Sjögren’s disease.

Our lead product candidate, RSLV-132, has the potential to prevent the inflammation that causes the debilitating symptoms of autoimmune diseases.

Address

1951 NW 7th Avenue, Suite 300
Miami, FL
33136

Telephone

(208)7277010

Website

Alerts

Be the first to know and let us send you an email when Resolve Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category